clinical trial · NCT06783257
Phase II Clinical Study of Vonorasan Fumarate Injection in the Treatment of Peptic Ulcer Bleeding
Shandong New Time Pharmaceutical Co., LTD·phase2·not yet recruiting·n = 150
Peptic Ulcer BleedingVonorasan fumarate injection1Vonorasan fumarate injection2Esomeprazole sodium for injection
brief summary
A Multicenter, Randomized, Double-Blind, Parallel-Group Phase II Clinical Trial to Evaluate the Efficacy and Safety of Vonoprazan Fumarate Injection for the Treatment of Peptic Ulcer Bleeding
started
Feb 1, 2025
primary completion
Feb 1, 2027
completion
Feb 1, 2027
last updated
Jan 20, 2025
detailed description
The trial was divided into screening period, treatment period and follow-up period.Subjects who did not meet the exclusion criteria were randomly assigned to vonorasan fumarate injection or esoprazole sodium for injection for 3 days; Safety was followed up to 2 days after the end of intravenous administration.
official title
A Multicenter, Randomized, Double-Blind, Parallel-Group Phase II Clinical Trial to Evaluate the Efficacy and Safety of Vonoprazan Fumarate Injection for the Treatment of Peptic Ulcer Bleeding
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol